RE: This afternoon8 Sep 2020 16:45
Inanaco I criticised the BoD where I thought necessary and give praise equally where I consider they have done a good job.
Prior to the fund raise to me there were questions of their ability to progress the science and monetise the assets.
Since then they have had a successful fund raise,great institutional support,UKRI funding for Covid 19 Vax and advanced commercial discussion on a mAB deal.
Imo they have changed the landscape but they have been here before SCIB 2 and CRUK/GC/Bion Tech Collaboration/SCIB 1 Combo/Moditope a few years ago but they did not push on so the SP dived and I criticised the BoD.
They have another chance and once again I am positive.
The difference between us is I look at independent evidence to justify my investment and am prepared to challenge my position rather than just a blind adherence to it must end up at £8 a share and a refusal to countenance any other views.
But no matter we all make our own decisions